Eprinomectin B1a

• Description :

  Eprinomectin B1a is a Eprinomectin (HY-12643) metabolite (an antiparasitic compound) [1].

• UNSPSC :

  12352005

• Hazard Statement :

  H315-H319

• Target :

  Drug Metabolite; Parasite

• Related Pathways :

  Anti-infection; Metabolic Enzyme/Protease

• Field of Research :

  Infection

• Smiles :

  O[C@]1([C@](C=C2C)([H])C(O[C@]3([H])C[C@](O[C@]4([H])[C@@H](C)CC)(C=C[C@@H]4C)O[C@@](C/C=C5\C)([H])C3)=O)[C@]([C@@H]2O)([H])OC/C1=C\C=C\[C@@H]([C@@H]5O[C@H](O[C@H]6C)C[C@@H]([C@H]6O[C@H](O[C@H]7C)C[C@@H]([C@@H]7NC(C)=O)OC)OC)C

• Molecular Formula :

  C50H75NO14

• Molecular Weight :

  914.13

• Precautions :

  P264-P280-P302+P352-P305+P351+P338-P362+P364

• References & Citations :

  [1]Kvaternick V, et al. Pharmacokinetics and metabolism of eprinomectin in cats when administered in a novel topical combination of fipronil, (S) -methoprene, eprinomectin and praziquantel. Vet Parasitol. 2014 Apr 28;202 (1-2) :2-9.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [133305-88-1]